Faster infusion rates can cause chest tightness, nausea or flushing, which is why careful pacing and monitoring are essential
In an evidence-based approach, the key points contributing to this consensus with respect to the clinical impact and benefits of GLP-1 RAs and their use in special populations are as follows: Clinical impact of GLP-1 RAs: GLP-1 RAs improve glucose homeostasis by enhancing glucose-dependent insulin secretion, by suppressing inappropriately elevated glucagon levels, both in fasting and postprandial states (Grade A
also protects against UV-driven collagen degradation
Considering the clinical 1b study data of the small molecule candidate drug GSBR-1290 released by Structure in October, Pfizer's newly launched small molecule project is undoubtedly facing significant external pressure
Academic institutions, biotechnology companies, and pharmaceutical organizations continue to investigate innovative receptor-targeting compounds aimed at improving our understanding of obesity, metabolism, and related biological pathways
Retrieved April 23, 2022